David Zach

418 total citations
15 papers, 308 citations indexed

About

David Zach is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, David Zach has authored 15 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in David Zach's work include Cardiovascular Function and Risk Factors (8 papers), Cardiomyopathy and Myosin Studies (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). David Zach is often cited by papers focused on Cardiovascular Function and Risk Factors (8 papers), Cardiomyopathy and Myosin Studies (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). David Zach collaborates with scholars based in Austria, Germany and Portugal. David Zach's co-authors include Christoph Beglinger, Pius Hildebrand, Lucio C. Rovati, Abhay Varma, Paul J. Müller, Kai Zhang, Brian C. Wilson, Stuart K. Bisland, Lothar Lilge and Eduardo H. Moriyama and has published in prestigious journals such as The Lancet, European Heart Journal and International Journal of Cardiology.

In The Last Decade

David Zach

11 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Zach Austria 6 99 91 76 71 61 15 308
Ana Maria Medina United States 8 64 0.6× 25 0.3× 29 0.4× 33 0.5× 62 1.0× 28 257
Maria Metaxari Greece 9 258 2.6× 31 0.3× 86 1.1× 61 0.9× 49 0.8× 11 395
Korhan Asal Türkiye 12 186 1.9× 24 0.3× 45 0.6× 84 1.2× 42 0.7× 21 421
Takaki Mizusawa Japan 11 136 1.4× 43 0.5× 83 1.1× 10 0.1× 64 1.0× 37 522
Holli Shumaker United States 6 80 0.8× 26 0.3× 137 1.8× 23 0.3× 215 3.5× 8 335
Yuchen Tian China 7 73 0.7× 32 0.4× 15 0.2× 8 0.1× 107 1.8× 12 391
Zsolt Balla Hungary 12 166 1.7× 33 0.4× 29 0.4× 5 0.1× 60 1.0× 19 290
Masaharu Higashida Japan 11 140 1.4× 17 0.2× 150 2.0× 40 0.6× 55 0.9× 52 356
G. VanDeventer United States 5 343 3.5× 36 0.4× 220 2.9× 163 2.3× 28 0.5× 7 507
Lichuan Liang China 9 76 0.8× 17 0.2× 34 0.4× 6 0.1× 205 3.4× 19 442

Countries citing papers authored by David Zach

Since Specialization
Citations

This map shows the geographic impact of David Zach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Zach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Zach more than expected).

Fields of papers citing papers by David Zach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Zach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Zach. The network helps show where David Zach may publish in the future.

Co-authorship network of co-authors of David Zach

This figure shows the co-authorship network connecting the top 25 collaborators of David Zach. A scholar is included among the top collaborators of David Zach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Zach. David Zach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cejka, Vladimir, Ewald Kolesnik, David Zach, et al.. (2025). Prognostic Impact of Gait Speed, Muscle Strength and Muscle Mass in Chronic Heart Failure—A Prospective Cohort Study. ESC Heart Failure. 12(3). 2113–2124.
2.
Debonnaire, Philippe, Karl Dujardin, Nicolas Verheyen, et al.. (2025). Tafamidis in octogenarians with wild-type transthyretin cardiac amyloidosis: an international cohort study. European Heart Journal. 46(11). 1057–1070. 11 indexed citations
3.
Zach, David, Markus Wallner, Dirk von Lewinski, et al.. (2024). Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study. Journal of Clinical Medicine. 13(19). 5966–5966. 7 indexed citations
4.
Zach, David, Alexander Peikert, Peter P. Rainer, et al.. (2024). The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure—A Prospective Study. Journal of Clinical Medicine. 13(7). 1930–1930. 5 indexed citations
5.
Verheyen, Nicolas, Nikolaos Bonaros, Daniel Dalos, et al.. (2024). Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy. Wiener klinische Wochenschrift. 136(S15). 571–597.
6.
Posch, Florian, Markus Wallner, Peter P. Rainer, et al.. (2023). Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort. European Journal of Internal Medicine. 118. 73–81. 2 indexed citations
7.
Verheyen, Nicolas, David Zach, Andreas Zirlik, et al.. (2023). Spatial relationship between mitral valve and ventricular septum assessed by resting echocardiography to diagnose left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. European Heart Journal - Cardiovascular Imaging. 24(6). 710–718. 5 indexed citations
8.
Zach, David, Ewald Kolesnik, Hubert Seggewiß, et al.. (2023). Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy. International Journal of Cardiology. 399. 131661–131661. 4 indexed citations
9.
Kolesnik, Ewald, Rainer W. Lipp, Tobias Niedrist, et al.. (2023). Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis. European Heart Journal. 44(Supplement_2).
10.
Verheyen, Nicolas, Kathrin Danninger, Franz Duca, et al.. (2022). Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis—A Retrospective Austrian Multicenter Study. Biomedicines. 10(12). 3052–3052. 2 indexed citations
11.
12.
Zach, David, Klemens Ablasser, Ewald Kolesnik, et al.. (2021). Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry. Genes. 12(10). 1469–1469. 12 indexed citations
13.
Zach, David, Klemens Ablasser, Ewald Kolesnik, et al.. (2021). Advanced Isolated Light Chain Amyloid Cardiomyopathy with Negative Immunofixation and Normal Free Light Chain Ratio. ESC Heart Failure. 8(4). 3397–3402. 1 indexed citations
14.
Bogaards, Arjen, Abhay Varma, Kai Zhang, et al.. (2005). Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development. Photochemical & Photobiological Sciences. 4(5). 438–442. 65 indexed citations
15.
Beglinger, Christoph, et al.. (1989). ROLE OF CHOLECYSTOKININ IN REGULATION OF GASTROINTESTINAL MOTOR FUNCTIONS. The Lancet. 334(8653). 12–15. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026